4,892
Views
62
CrossRef citations to date
0
Altmetric
Reviews

Magnetic nanoparticles in cancer diagnosis and treatment: a review

, , , , , , , & show all
Pages 1-5 | Received 25 Nov 2015, Accepted 04 Feb 2016, Published online: 25 Mar 2016

References

  • Abdeen S, Praseetha PK. 2013. Diagnostics and treatment of metastatic cancers with magnetic nanoparticles. J Nanomed Biother Discov. 3:115.
  • Akbarzadeh A, Samiei M, Davaran S. 2012a. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 7:1–13.
  • Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012b. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol. 10:46–58.
  • Anari E, Akbarzadeh A, Zarghami N. 2015. Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1029633.
  • Anderson JM, Shive MS. 2012. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 64:72–82.
  • Asin L, Ibarra MR, Tres A, Goya GF. 2012a. By magnetic, controlled cell death. Pharm Res. 29:1319–1327.
  • Asin L, Ibarra MR, Tres A, Goya GF. 2012b. Controlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentration. Pharm Res. 29:1319–1327.
  • Askari S, Salehi R, Zarghami N, Akbarzadeh A, Rahmati-Yamchi M. 2015. The anticancer effects of biodegradable nanomagnetic dual natural components on the leptin gene expression in lung cancer. [Epub ahead of print]. doi: 10.3109/21691401.2015.1101000.
  • Babu A, Templeton AK, Munshi A, Ramesh R. 2013. Nanoparticle-based drug delivery for therapy of lung cancer: progress and challenges. J Nanomater. 2013:863951.
  • Baviskar DT, Amritkar AS, Chaudhari HS, Jain DK. 2012. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes. Die Pharmazie Int J Pharm Sci. 67:701–705.
  • Cervadoro A, Giverso C, Pande R, Sarangi S, Preziosi L, Wosik J, Brazdeikis A, Decuzzi P. 2013. Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles. PLoS One. 8:e57332.
  • Chung JH, Kim YK, Kim KH, Kwon TY, Vaezmomeni SZ, Samiei M, et al. 2016. Synthesis, characterization, biocompatibility of hydroxyapatite-natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 44:277–284.
  • Colombo M, Carregal-Romero S, Casula MF, Gutiérrez L, Morales MP, Böhm IB, Parak WJ. 2012. Biological applications of magnetic nanoparticles. Chem Soc Rev. 41:4306–4334.
  • Daraee H, Pourhassanmoghadam M, Akbarzadeh A, Zarghami N, Rahmati-Yamchi M. 2015. Gold nanoparticle-oligonucleotide conjugate to detect the sequence of lung cancer biomarker. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi:10.3109/21691401.2015.1031905.
  • Ding W, Wang F, Zhang J, Guo Y, Ju S, Wang H. 2013. A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern. Nanotechnology. 24:375101.
  • Disch S, Wetterskog E, Hermann RP, Wiedenmann A, Vainio U, Salazar-Alvarez G, Bergström L, Brückel T. 2012. Quantitative spatial magnetization distribution in iron oxide nanocubes and nanospheres by polarized small-angle neutron scattering. New J Phys. 14:013025.
  • Dürr S, Janko C, Lyer S, Tripal P, Schwarz M, Zaloga J, Tietze R, Alexiou C. 2013. Magnetic nanoparticles for cancer therapy. Nanotechnol Rev. 2:395–409.
  • Eatemadi A, Daraee H, Zarghami N, Yar HM, Akbarzadeh A. 2016a. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 44:111–121.
  • Ebrahimi E, Akbarzadeh A, Abbasi E, Khandaghi AA, Abasalizadeh F, Davaran S. 2016a. Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artif Cells Nanomed Biotechnol. 44:290–297.
  • Ebrahimi E, Khandaghi A, Valipour F, Babaie S, Asghari F, Motaali S, et al. 2016b. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers. Artif Cells Nanomed Biotechnol. 44:550–558.
  • Fallahzadeh S, Bahrami H, Akbarzadeh A, Tayarani M. 2010. High-isolation dual-frequency operation patch antenna using spiral defected microstrip structure. IEEE Antenn Wirel Propagat Lett. 9:122–124.
  • Faraji M, Yamini Y, Rezaee M. 2010. Magnetic nanoparticles: synthesis, stabilization, functionalization, characterization, and applications. J Iranian Chem Soc. 7:1–37.
  • Furlani EP. 2010. Magnetic biotransport: analysis and applications. Materials. 3:2412–2446.
  • Gobbo OL, Sjaastad K, Radomski MW, Volkov Y, Prina-Mello A. 2015. Magnetic nanoparticles in cancer theranostics. Theranostics. 5:1249–1263.
  • Gorjikhah F, Davaran S, Salehi R, Bakhtiari M, Hasanzadeh A, Panahi Y, Emamverdy M, Akbarzadeh A. 2016. Improving “lab-on-a-chip” techniques using biomedical nanotechnology: a review. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1129619.
  • Gudoshnikov SA, Ya Liubimov B, Usov NA. 2012. Hysteresis losses in a dense superparamagnetic nanoparticle assembly. AIP Adv. 2:012143.
  • Gudoshnikov SA, Liubimov BY, Sitnov YS, Skomarovsky VS, Usov NA. 2013. AC magnetic technique to measure specific absorption rate of magnetic nanoparticles. J Superconduct Novel Magn. 26:857–860.
  • Gupta AK, Gupta M. 2005. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 26:3995–4021.
  • Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H. 2010. EGFRvIII antibody–conjugated iron oxide nanoparticles for magnetic resonance imaging–guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 70:6303–6312.
  • Jiang L, Li X, Liu L, Zhang Q. 2013. Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer. Nanoscale Res Lett. 8:1–11.
  • Kimura S, Egashira K, Chen L, Nakano K, Iwata E, Miyagawa M, et al. 2009. Nanoparticle-mediated delivery of nuclear factor κB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension. 53:877–883.
  • Kong M, Li X, Wang C, Ding C, Dong A, Duan Q, Shen Z. 2012. Tissue distribution and cancer growth inhibition of magnetic lipoplex-delivered type 1 insulin-like growth factor receptor shRNA in nude mice. Acta Biochim Et Biophys Sin. 44:591–596.
  • Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev. 47:65–81.
  • Landi GT. 2013. Simple models for the heating curve in magnetic hyperthermia experiments. J Magn Magn Mater. 326:14–21.
  • Lima-Tenório MK, Gómez Pineda EA, Ahmad NM, Fessi H, Elaissari A. 2015. Magnetic nanoparticles: in vivo cancer diagnosis and therapy. Int J Pharm. 493:313–327.
  • Mahmoudi M, Laurent S, Shokrgozar MA, Hosseinkhani M. 2011. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical properties of nanoparticles. ACS Nano. 5:7263–7276.
  • Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, et al. 2011. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 103:317–324.
  • McCarthy JR, Weissleder R. 2008. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev. 60:1241–1251.
  • Munaweera I, Shi Y, Koneru B, Saez R, Aliev A, Di Pasqua AJ, Balkus KJ Jr. 2015. Chemoradiotherapeutic magnetic nanoparticles for targeted treatment of nonsmall cell lung cancer. Mol Pharm. 12:3588–3596.
  • Namiki Y, Namiki T, Yoshida H, Ishii Y, Tsubota A, Koido S, et al. 2009. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol. 4:598–606.
  • Nasrabadi HT, Abbasi E, Davaran S, Kouhi M, Akbarzadeh A. 2016. Bimetallic nanoparticles: Preparation, properties, and biomedical applications. Artif Cells Nanomed Biotechnol. 44:376–380.
  • Obaidat IM, Issa B, Haik Y. 2015. Magnetic properties of magnetic nanoparticles for efficient hyperthermia. Nanomaterials. 5:63–89.
  • Petters C, Irrsack E, Koch M, Dringen R. 2014. Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochem Res. 39:1648–1660.
  • Pilehvar-Soltanahmadi Y, Akbarzadeh A, Moazzez-Lalaklo N, Zarghami N. 2015. An update on clinical applications of electrospun nanofibers for skin bioengineering. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi:10.3109/21691401.2015.1036999.
  • Rivas J, Bañobre-López M, Piñeiro-Redondo Y, Rivas B, López-Quintela MA. 2012. Magnetic nanoparticles for application in cancer therapy. J Magn Magn Mater. 324:3499–3502.
  • Sadhukha T, Wiedmann TS, Panyam J. 2013. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials. 34:5163–5171.
  • Salloum M, Ma R, Zhu L. 2009. Enhancement in treatment planning for magnetic nanoparticle hyperthermia: optimization of the heat absorption pattern. Int J Hyperthermia. 25:309–321.
  • Schroeder U, Sommerfeld P, Ulrich S, Sabel BA. 1998. Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci. 87:1305–1307.
  • Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 70:1–20.
  • Sukumar UK, Bhushan B, Dubey P, Matai I, Sachdev A, Packirisamy G. 2013. Emerging applications of nanoparticles for lung cancer diagnosis and therapy. Int Nano Lett. 3:1–17.
  • Sun C, Lee JSH, Zhang M. 2008. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 60:1252–1265.
  • Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, Badrzadeh F, Rahmati-Yamchi M. 2016. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 44:423–430.
  • Tartaj P, Morales MDD, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ. 2003. The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys. 36:R182–R197.
  • Tartaj P, Morales MP, Veintemillas-Verdaguer S, Gonzalez-Carreño T, Serna CJ. 2006. Synthesis, properties and biomedical applications of magnetic nanoparticles. Handb Magn Mater. 16:403–482.
  • Thakor AS, Gambhir SS. 2013. Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J Clin. 63:395–418.
  • Tiwari M. 2012. Nano cancer therapy strategies. J Cancer Res Ther. 8:19–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.